Epidemiological studies have also demonstrated that apolipoproteins and the apoB/apoA1 ratio represent potential risk factors for the development of type 2 diabetes mellitus (T2DM) [3], insulin resistance [4], non-alcoholic fatty liver disease [5], metabolic syndrome [6], and cancer [7]. This evidence concerns the gene APOA1 and type 2 diabetes mellitus.